Incidental bladder cancer at initial urological workup of spinal cord injury patients.


Journal

Spinal cord series and cases
ISSN: 2058-6124
Titre abrégé: Spinal Cord Ser Cases
Pays: England
ID NLM: 101680856

Informations de publication

Date de publication:
29 06 2020
Historique:
received: 29 04 2020
accepted: 16 06 2020
revised: 13 06 2020
entrez: 1 7 2020
pubmed: 1 7 2020
medline: 10 8 2021
Statut: epublish

Résumé

Retrospective descriptive study. To compare histopathological findings and the long-term course of SCI patients with bladder cancer found incidentally at the initial urological workup to those diagnosed with bladder cancer many years after the onset of SCI. Spinal cord injury center in Germany. Data and follow-up of consecutive in- and out-patients with SCI admitted at a tertiary spinal cord injury center between January 1, 1998 and December 31, 2018 were screened retrospectively. All patients with acquired SCI were evaluated for pathological findings in the urinary bladder present at the time of SCI on the initial urological workup. Data of 37 long-term SCI patients from the same center with diagnosed bladder cancer and data of the general German population served as reference groups. Descriptive statistics were applied. In total, four patients with bladder cancer at initial urological workup were assessed. They all had non-muscle invasive bladder cancer. Two of the patients were cystectomized 34 and 106 months after first bladder cancer diagnosis, due to relapsing tumor and progressive renal failure, respectively. In both cases no tumor was found in the resected bladder. All four patients are currently alive with no tumor and a mean follow-up of 105 months. In incidental bladder cancer observed at the initial urological workup after acquired SCI, the duration of SCI, at least in the first 5 years, does not noticeably contribute to a poor prognosis, i.e., progression to muscle invasive bladder cancer (≥T2) or a higher grading (G3).

Identifiants

pubmed: 32601273
doi: 10.1038/s41394-020-0307-4
pii: 10.1038/s41394-020-0307-4
pmc: PMC7324388
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

55

Références

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
doi: 10.3322/caac.21492
Ismail S, Karsenty G, Chartier-Kastler E, Cussenot O, Compérat E, Rouprêt M, et al. Prevalence, management, and prognosis of bladder cancer in patients with neurogenic bladder: a systematic review. Neurourol Urodyn. 2018;37:1386–95.
doi: 10.1002/nau.23457
Gui-Zhong L, Li-Bo M. Bladder cancer in individuals with spinal cord injuries: a meta-analysis. Spinal Cord. 2017;55:341–5.
doi: 10.1038/sc.2016.151
Groah SL, Weitzenkamp DA, Lammertse DP, Whiteneck GG, Lezotte DC, Hamman RF. Excess risk of bladder cancer in spinal cord injury: evidence for an association between indwelling catheter use and bladder cancer. Arch Phys Med Rehab. 2002;83:346–51.
doi: 10.1053/apmr.2002.29653
Nahm LS, Chen Y, DeVivo MJ, Lloyd LK. Bladder cancer mortality after spinal cord injury over 4 decades. J Urol. 2015;193:1923–8.
doi: 10.1016/j.juro.2015.01.070
Böthig R, Tiburtius C, Fiebag K, Kowald B, Hirschfeld S, Thietje R, et al. Traumatic spinal cord injury confers bladder cancer risk to patients managed without permanent urinary catheterization: lessons from a comparison of clinical data with the national database. World J Urol. 2020. https://doi.org/10.1007/s00345-020-03077-3 .
Manach Q, Cussenot O, Rouprêt M, Gamé X, Chartier-Kastler E, Reus C, et al. Analysis of bladder cancer subtypes in neurogenic bladder tumors. Can J Urol. 2018;25:9161–7.
pubmed: 29524970
Welk B, McIntyre A, Teasell R, Potter P, Loh E. Bladder cancer in individuals with spinal cord injuries. Spinal Cord. 2013;51:516–21.
doi: 10.1038/sc.2013.33
Elliott SP. Screening for bladder cancer in individuals with spinal cord injury. J Urol. 2015;193:1880–1.
doi: 10.1016/j.juro.2015.03.069
Cameron AP, Rodriguez GM, Schomer KG. Systematic review of urological followup after spinal cord injury. J Urol. 2012;187:391–7.
doi: 10.1016/j.juro.2011.10.020
Cancer Research UK. 2018a. https://www.cancerresearchuk.org/about-cancer/bladder-cancer/types-stages-grades/stages . Accessed 6 June 2020.
Cancer Research UK. 2018b. https://www.cancerresearchuk.org/about-cancer/bladder-cancer/types-stages-grades/grades . Accessed 6 June 2020.
Rove KO, Husmann DA, Wilcox DT, Vricella GJ, Higuchi TT. Systematic review of bladder cancer outcomes in patients with spina bifida. J Pediatr Urol. 2017;13:456.e1–9.
doi: 10.1016/j.jpurol.2017.05.006
Meléndez M, Maroto A, Illescas T, Allué M, Castro L, Carreras E, et al. Bladder cancer in patients with spina bifida: observation from an adult clinic. Spinal Cord SerCases. 2018;4. https://doi.org/10.1038/s41394-018-0066-7 .
Stonehill WH, Dmochowski RR, Patterson AL, Cox CE. Risk factors for bladder tumors in spinal cord injury patients. J Urol. 1996;155:1248–50.
doi: 10.1016/S0022-5347(01)66232-3
Vereczkey ZA, Schmeidler J, Binard JE, Bauman WA. Bladder cancer risk in patients with spinal cord injury. J Spinal Cord Med. 1998;21:230–9.
doi: 10.1080/10790268.1998.11719532
West DA, Cummings JM, Longo WE, Virgo KS, Johnson FE, Parra RO. Role of chronic catheterization in the development of bladder cancer in patients with spinal cord injury. Urology. 1999;53:292–7.
doi: 10.1016/S0090-4295(98)00517-2
Pannek J. Transitional cell carcinoma in patients with spinal cord injury: a high risk malignancy? Urology. 2002;59:240–4.
doi: 10.1016/S0090-4295(01)01495-9
Hess MJ, Zhan EH, Foo DK, Yalla SV. Bladder cancer in patients with spinal cord injury. J Spinal Cord Med. 2003;26:335–8.
doi: 10.1080/10790268.2003.11753702
Kalisvaart JF, Katsumi HK, Ronningen LD, Hovey RM. Bladder cancer in spinal cord injury patients. Spinal Cord. 2010;48:257–61.
doi: 10.1038/sc.2009.118

Auteurs

Ralf Böthig (R)

Department of Neuro-Urology, Centre for Spinal Cord Injuries, BG Klinikum Hamburg, Hamburg, Germany. R.Boethig@bgk-hamburg.de.

Klaus Golka (K)

Clinical Occupational Medicine, Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund (IfADo), Dortmund, Germany.

Christian Tiburtius (C)

Department of Neuro-Urology, Centre for Spinal Cord Injuries, BG Klinikum Hamburg, Hamburg, Germany.

Oliver Balzer (O)

Department of Neuro-Urology, Centre for Spinal Cord Injuries, BG Klinikum Hamburg, Hamburg, Germany.

Birgitt Kowald (B)

Biomechanical Laboratory, BG Klinikum Hamburg, Hamburg, Germany.

Sven Hirschfeld (S)

Centre for Spinal Cord Injuries, BG Klinikum Hamburg, Hamburg, Germany.

Ines Kurze (I)

Department of Paraplegiology and Neuro-Urology, Centre for Spinal Cord Injuries, Zentralklinik Bad Berka, Bad Berka, Germany.

Wolfgang Schöps (W)

Urological Practice, Sankt Augustin, Germany.

Thura Kadhum (T)

Specialist Clinic for Psychosomatic Rehabilitation, Mittelrheinklinik, Boppard-Bad Salzig, Germany.

Roland Thietje (R)

Centre for Spinal Cord Injuries, BG Klinikum Hamburg, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH